Venturini, J., Baysal, M. A., Chakraborty, A., Fu, S., Hong, D. S., Piha-Paul, S. A., Naing, A., Ahnert, J. R., Yap, T. A., Dumbrava, E. E., Beck, J., Andersen, C., Kahle, M., Vining, D. J., Meric-Bernstam, F., Tsimberidou, A. M. (2026). Clinical outcomes of patients with TP53 pathway alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3152